Acute liver injury in the context of immune checkpoint inhibitor-related colitis treated with infliximab
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Acute liver injury in the context of immune checkpoint inhibitor-related colitis treated with infliximab ; volume:7 ; number:1 ; day:18 ; month:2 ; year:2019 ; pages:1-8 ; date:12.2019
Journal for ImmunoTherapy of Cancer ; 7, Heft 1 (18.2.2019), 1-8, 12.2019
- Urheber
-
Zhang, Hao Chi
Luo, Wenyi
Wang, Yinghong
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40425-019-0532-1
- URN
-
urn:nbn:de:101:1-2019031718585735925871
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zhang, Hao Chi
- Luo, Wenyi
- Wang, Yinghong
- SpringerLink (Online service)
Ähnliche Objekte (12)
De novo ulcerative colitis after kidney transplantation treated with infliximab
Population pharmacokinetic analysis of infliximab in patients with ulcerative colitis
Steroid-Refractory Acute Severe Ulcerative Colitis in Infliximab-Experienced Patients
Hodgkin's Lymphoma in Crohn's Disease Treated with Infliximab
Infliximab-associated fulminant hepatic failure in ulcerative colitis: a case report
Pregnancy-Induced Sweet’s Syndrome Treated with Infliximab
Infliximab und Adalimumab in der Therapie der Colitis ulcerosa : eine retrospektive Analyse
Complicated Crohn's-like colitis, associated with Hermansky-Pudlak syndrome, treated with Infliximab: a case report and brief review of the literature
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis
Evaluation of Proactive Therapeutic Drug Monitoring Application in Infliximab Users in Ulcerative Colitis
Colonic Dilatation Complicating Acute Severe Ulcerative Colitis Managed Successfully with Accelerated Infliximab Dosing
Treatment of corticosteroid refractory immune checkpoint inhibitor myocarditis with Infliximab: a case series
De novo ulcerative colitis after kidney transplantation treated with infliximab
Population pharmacokinetic analysis of infliximab in patients with ulcerative colitis
Steroid-Refractory Acute Severe Ulcerative Colitis in Infliximab-Experienced Patients
Hodgkin's Lymphoma in Crohn's Disease Treated with Infliximab
Infliximab-associated fulminant hepatic failure in ulcerative colitis: a case report
Pregnancy-Induced Sweet’s Syndrome Treated with Infliximab
Infliximab und Adalimumab in der Therapie der Colitis ulcerosa : eine retrospektive Analyse
Complicated Crohn's-like colitis, associated with Hermansky-Pudlak syndrome, treated with Infliximab: a case report and brief review of the literature
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis
Evaluation of Proactive Therapeutic Drug Monitoring Application in Infliximab Users in Ulcerative Colitis
Colonic Dilatation Complicating Acute Severe Ulcerative Colitis Managed Successfully with Accelerated Infliximab Dosing
Treatment of corticosteroid refractory immune checkpoint inhibitor myocarditis with Infliximab: a case series
De novo ulcerative colitis after kidney transplantation treated with infliximab
Population pharmacokinetic analysis of infliximab in patients with ulcerative colitis
Steroid-Refractory Acute Severe Ulcerative Colitis in Infliximab-Experienced Patients
Hodgkin's Lymphoma in Crohn's Disease Treated with Infliximab
Infliximab-associated fulminant hepatic failure in ulcerative colitis: a case report
Pregnancy-Induced Sweet’s Syndrome Treated with Infliximab
Infliximab und Adalimumab in der Therapie der Colitis ulcerosa : eine retrospektive Analyse
Complicated Crohn's-like colitis, associated with Hermansky-Pudlak syndrome, treated with Infliximab: a case report and brief review of the literature
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis
Evaluation of Proactive Therapeutic Drug Monitoring Application in Infliximab Users in Ulcerative Colitis
Colonic Dilatation Complicating Acute Severe Ulcerative Colitis Managed Successfully with Accelerated Infliximab Dosing